Screener
Tandem Diabetes Care TNDM Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:EquityMethodInvestments.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
| Assets | June 30, 2026 / (Unaudited) | December 31, 2025 / (Note 1) |
|---|---|---|
| Total current assets | 804,639 | 618,143 |
| Property and equipment, net | 84,501 | 83,580 |
| Operating lease right-of-use assets | 100,185 | 96,172 |
| Equity method investment | 132,271 | 60,351 |
| Other long-term assets | 32,606 | 22,866 |
| Total assets | $1,154,202 | $881,112 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Financial Statements.
FAQ
- What is Tandem Diabetes Care's equity method investments?
- Tandem Diabetes Care (TNDM) reported equity method investments of $132.27M in Q2 2026.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Tandem Diabetes Care's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude